Cel-Sci regulatory update

Cel-Sci Corp. (CELID) The FDA authorized the export to Canada of CELID's Multikine cancer drug, a mixture of Interleukin-2 and other cytokines. Multikine is poised to enter a Phase I/II trial in Cana...